GSK - GSK Plc - ADR
Close
43.91
0.170 0.387%
Share volume: 3,129,062
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$43.74
0.17
0.39%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-04-27 | 2022-07-27 | 2022-11-02 | 2023-03-10 | 2023-04-26 | 2023-07-26 | 2023-11-01 | 2024-03-05 | |
| Total revenue | 12.827 B | 8.406 B | 8.695 B | 5.549 B | 8.616 B | 9.063 B | 9.937 B | 11.020 B | |
| Cost of revenue | 4.840 B | 2.640 B | 2.691 B | 1.388 B | 2.408 B | 2.439 B | 2.771 B | 3.292 B | |
| Gross profit | 7.987 B | 5.766 B | 6.004 B | 4.161 B | 6.207 B | 6.623 B | 7.166 B | 7.727 B | |
| -27.81% | 4.13% | -30.70% | 49.20% | 6.70% | 8.19% | 7.84% | |||
| Operating expenses | 5.261 B | 4.013 B | 3.778 B | 3.716 B | 4.218 B | 4.557 B | 4.721 B | 6.387 B | |
| Selling general and admin | 3.730 B | 2.506 B | 2.283 B | 1.609 B | 2.656 B | 2.863 B | 2.800 B | 3.635 B | |
| Research and development | 1.531 B | 1.507 B | 1.495 B | 2.107 B | 1.562 B | 1.693 B | 1.921 B | 2.752 B | |
| Total expenses | 10.100 B | 6.653 B | 6.469 B | 5.104 B | 6.626 B | 6.996 B | 7.493 B | 9.679 B | |
| -34.13% | -2.76% | -21.10% | 29.83% | 5.58% | 7.10% | 29.18% | |||
| Operating income | 2.727 B | 1.753 B | 2.226 B | 444.599 M | 1.989 B | 2.067 B | 2.444 B | 1.340 B | |
| Ebit | 2.908 B | 1.943 B | 2.508 B | 705.660 M | 2.210 B | 2.350 B | 2.825 B | 1.664 B | |
| Pretax income | 3.407 B | 1.087 B | 1.124 B | 1.190 B | 2.364 B | 2.509 B | 2.184 B | 668.013 M | |
| -68.10% | 3.40% | 5.92% | 98.55% | 6.13% | -12.92% | -69.42% | |||
| Income tax | 565.276 M | 181.966 M | 258.774 M | -150.687 M | 342.102 M | 305.539 M | 313.463 M | 1.964 M | |
| Net income basic | 2.363 B | 1.017 B | 11.456 B | 3.258 B | 1.847 B | 2.050 B | 1.786 B | 594.885 M | |
| -56.99% | 1,026.91% | -71.56% | -43.31% | 11.02% | -12.91% | -66.69% | |||
| Net income | 2.363 B | 1.017 B | 11.456 B | 3.258 B | 1.847 B | 2.050 B | 1.786 B | 594.885 M | |
| -56.99% | 1,026.91% | -71.56% | -43.31% | 11.02% | -12.91% | -66.69% |